Researchers seek new pancreatic cancer biomarkers

Targeting the cancer with one of the poorest survival rates in the world, the National Cancer Institute is funding a $2.3 million project to develop new molecular biomarkers for pancreatic cancer. Researchers from Van Andel Institute and Emory University will lead the 5-year project, along with researchers from other prominent institutions in the U.S. The study will focus on carbohydrate structures on the surface of cancer cells, known as glycans, using a technique called "shotgun glycomics." Press release | Article (reg. req.)

Suggested Articles

BD will begin working with Babson Diagnostics to help bring its lab-quality device for collecting blood from capillaries into retail pharmacies.

The former CEO of the molecular testing company Foundation Medicine, Troy Cox, has been named chairman of the Swiss big data firm Sophia Genetics.

Researchers at MIT used a machine-learning algorithm to uncover the potent antibiotic properties hiding within an old small-molecule candidate.